ResearcherUniversity Hospitals Seidman Cancer CenterNo recent work listed

Aryavarta M. S. Kumar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3621-4962; OpenAlex author ID A5039371082. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper

Papers 1

Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection. Last author DOI 10.1111/1751-2980.12551 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alok A. Khorana · 1 shared paper, 2017 · strength 0.08
- Paper Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at re… DOI 10.1111/1751-2980.12551 ↗
Richard Matthew Walsh · 1 shared paper, 2017 · strength 0.08
- Paper Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at re… DOI 10.1111/1751-2980.12551 ↗
Camille A. Berriochoa · 1 shared paper, 2017 · strength 0.08
- Paper Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at re… DOI 10.1111/1751-2980.12551 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.